Drug Targeting Complexity : Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

個数:
  • 予約

Drug Targeting Complexity : Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

  • 現在予約受付中です。出版後の入荷・発送となります。
    重要:表示されている発売日は予定となり、発売が延期、中止、生産限定品で商品確保ができないなどの理由により、ご注文をお取消しさせていただく場合がございます。予めご了承ください。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 500 p.
  • 言語 ENG
  • 商品コード 9780443438462

Full Description

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy presents a rigorous examination of advanced strategies for the selective targeting of neoplastic cells and their distinct microenvironments. This comprehensive volume elucidates both tissue-specific and tumor-specific molecular targets, clarifying how these methodologies can significantly enhance therapeutic precision while mitigating off-target effects. The initial section of the text provides an in-depth analysis of tissue-specific regulatory targets across various organs, including the liver, lungs, brain, skin, and bones. It delineates the critical mediators and mechanisms that govern tumor immunity, thereby identifying novel therapeutic avenues.

Each chapter meticulously evaluates key regulatory molecules such as TGF-β, CTLA-4, and IL-10, exploring their roles in tumorigenesis and the potential for targeted interventions across a spectrum of malignancies. Subsequent sections focus on tumor tissue-specific molecular targets, encompassing immunological checkpoints, growth factors, and signaling pathways pertinent to cancers of the liver, stomach, ovary, prostate, and colon. The text provides insights into the application of monoclonal antibodies and molecular inhibitors as strategies to impede cancer progression and address therapeutic resistance. Concluding chapters address emerging therapeutic paradigms, including precision medicine and nanotechnology.

Contents

Part I. Tissue-Specific Targets
1. Brain-Specific Regulatory T Cell (Treg) Mediators
2. Liver-Specific Regulatory T Cell Mediators
3. Lung-Specific Regulatory T Cell Mediators
4. Adrenal Gland-Specific Regulatory T Cell Mediators
5. Lymph Node-Specific Regulatory T Cell Mediators
6. Skin-Specific Regulatory T Cell Mediators
7. Bone-Specific Regulatory T Cell Mediators
8. Colon-Specific Regulatory T Cell Mediators
9. Breast-Specific Regulatory T Cell Mediators

Part II. Tumor Tissue-Specific Targets
10. Molecular Targets for Liver Cancer
11. Molecular Targets for Gastric Cancer
12. Molecular Targets for Breast Cancer
13. Molecular Targets for Ovarian Cancer
14. Molecular Targets in Prostate Cancer
15. Molecular Targets in Colon Cancer
16. Molecular Targets in Lung Cancer
17. Molecular Targets in Blood Cancer

Part III. Advanced Therapeutic Approaches
18. Human Genetic Mutation-Based Targeting
19. Microbiome in Cancer Immunotherapy and Cancer Progression
20. Precision Medicine
21. Future Directions and Challenges in Cancer Targeting Therapies

最近チェックした商品